Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, increasing prevalence of brain tumor, and rising funding for neurology research.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The neurophotonics market is segmented as below:
By Application
- Research
- Therapeutics
By Type
- Microscopy
- Spectroscopy
- Multimodal
By End-user
- Academic and research institutes
- Hospitals and clinics
- Pharmaceutical and biotechnology
- Neurotechnology startups
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the neurophotonics market covers the following areas:
- Neurophotonics Market sizing
- Neurophotonics Market forecast
- Neurophotonics Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global neurophotonics market: Artinis Medical Systems, Cairn Research Ltd., Carl Zeiss AG, Femtonics Ltd., Hemophotonics S.L., Hitachi Ltd., HORIBA Ltd., Inscopix Inc., Intelligent Imaging Innovations Inc., ISS Inc., Leica Microsystems, Nanoscope Technologies LLC, NIRx Medical Technologies LLC, Thermo Fisher Scientific Inc., and Vielight Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is future opportunities in neurophotonics."
According to the report, one of the major drivers for this market is the increasing prevalence of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Artinis Medical Systems
- Cairn Research Ltd.
- Carl Zeiss AG
- Femtonics Ltd.
- Hemophotonics S.L.
- Hitachi Ltd.
- HORIBA Ltd.
- Inscopix Inc.
- Intelligent Imaging Innovations Inc.
- ISS Inc.
- Leica Microsystems
- Nanoscope Technologies LLC
- NIRx Medical Technologies LLC
- Thermo Fisher Scientific Inc.
- Vielight Inc.